Back to discover
Drug

Technetium

Late-stage clinical development
RxNorm2571856
1
Research papers
2
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Implementation of Fluorescence Imaging Using Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer

Clinical trial2026-07-01Primary completion · ClinicalTrials.gov

Superparamagnetic Iron Oxide for Sentinel Lymph Node Localization in Patients With Cutaneous Melanoma, a Randomized Phase III Multi-center Non- Inferiority Trial: MagMen-II

Clinical trial2026-04-27Results expected Q4 2029 · ClinicalTrials.gov

A Phase 3b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Caffeine Intake on Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) in Subjects Administered Regadenoson

Clinical trial2024-12-03Results posted · ClinicalTrials.gov

Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGIT.

Research2023-09-20Frontiers in immunology

Does Opioid Induced Swallowing Difficulty Lead to Elevated Risk for Pulmonary Aspiration?

Clinical trial2012-05-01Completed · ClinicalTrials.gov

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Technetium
RxNorm CUI
2571856

Clinical trials

4 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
4
registered trials across all phases
LATEST COMPLETION 2012
2
Active studies
2
Recruiting
4
Late-stage (III+)
2
Completed
PHASE DISTRIBUTIONn = 4
Phase 32Phase 41Phase N / A1

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Major research themes3
Neoplasms1Single-Chain Antibodies1Single-Domain Antibodies1
Journals, researchers & institutions
Top journals
  • Frontiers in immunology1
Leading researchers
  • Awad RM1
  • Breckpot K1
  • Ceuppens H1
  • De Groof TWM1
  • de Mey W1
  • Devoogdt N1
  • Ertveldt T1
  • Meeus F1
Leading institutions
free-text, unnormalised
  • Laboratory for Cellular and Molecular Immunology (CMIM)1
  • Laboratory for Molecular and Cellular Therapy (LMCT)1
  • Laboratory of Molecular Imaging and Therapy (MITH)1
  • Vlaams Instituut voor Biotechnologie (VIB) Center for Inflammation Research1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials